Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

China NMPA clears start of phase III trial of Endostar for malignant thoracoabdominal effusions

March 22, 2021

Studies identify novel PDAC therapeutic target

March 22, 2021

enGene enrolls patients with non-muscle invasive bladder cancer in phase I/II study of EG-70

March 22, 2021

Janssen Pharmaceutica synthesizes new DHODH inhibitors

March 22, 2021

Etern Biopharma presents new FGFR inhibitors

March 22, 2021

Korea Institute of Science and Technology divulges protein kinase inhibitors

March 22, 2021

UNM Rainforest Innovations patents ER modulators

March 22, 2021

Peptomyc obtains approval for first-in-human phase I/II study of Omomyc

March 19, 2021

Kainos Medicine synthesizes new CD73 inhibitors

March 19, 2021

Exelixis collaborates with Merck KGaA and Pfizer to evaluate XL-092 plus avelumab in UC

March 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....